Relapse prevention interventions for smoking cessation

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 12, 2013, Pages

  Hajek, Peter ^a   Stead, Lindsay F ^b   West, Robert ^c   Jarvis, Martin ^c   Hartmann Boyce, Jamie ^b   Lancaster, Tim ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; BENZAZEPINE DERIVATIVE; CHEWING GUM; NICOTINE; NICOTINIC AGENT; QUINOXALINE DERIVATIVE; VARENICLINE;

ABSTINENCE; BEHAVIOR THERAPY; FOLLOW UP; HEALTH CARE ACCESS; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INTERVENTION STUDY; MEDICATION THERAPY MANAGEMENT; NICOTINE REPLACEMENT THERAPY; PATIENT COMPLIANCE; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; RELAPSE; REVIEW; SMOKING CESSATION; SMOKING CESSATION PROGRAM; SYSTEMATIC REVIEW; TELEMEDICINE; TRAINING; TREATMENT DURATION; CHEWING GUM; FEMALE; MALE; META ANALYSIS; PREVENTION AND CONTROL; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECONDARY PREVENTION; SMOKING; METHODOLOGY; RECURRENT DISEASE;

BEHAVIOR THERAPY; BENZAZEPINES; CHEWING GUM; FEMALE; HUMANS; MALE; NICOTINE; NICOTINIC AGONISTS; PREGNANCY; QUINOXALINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SECONDARY PREVENTION; SMOKING; SMOKING CESSATION; RECURRENCE;

EID: 84888390555     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD003999.pub4     Document Type: Review

References (153)

1. Becona E, Vazquez FL. Does using relapse prevention increase the efficacy of a program for smoking cessation? An empirical study. Psychological Reports 1997;81(1):291-6.
2. Borland R, Balmford J, Hunt D. The effectiveness of personally tailored computer-generated advice letters for smoking cessation. Addiction 2004;99:369-77.
3. Brandon TH, Zelman DC, Baker TB. Effects of maintenance sessions on smoking relapse: delaying the inevitable?. Journal of Consulting and Clinical Psychology 1987;55:780-2.
4. Brandon TH, Collins BN, Juliano LM, Lazev AB. Preventing relapse among former smokers: a comparison of minimal interventions through telephone and mail. Journal of Consulting and Clinical Psychology 2000;68:103-13.
5. Brandon TH, Meade CD, Herzog TA, Chirikos TN, Webb MS, Cantor AB. Efficacy and cost-effectiveness of a minimal intervention to prevent smoking relapse: dismantling the effects of amount of content versus contact. Journal of Consulting and Clinical Psychology 2004;72:797-800.
6. Chirikos TN, Herzog TA, Meade CD, Webb MS, Brandon TH. Cost-effectiveness analysis of a complementary health intervention: the case of smoking relapse prevention. International Journal of Technology Assessment in Health Care 2004;20:475-80.
7. Buchkremer G, Minneker E, Block M. Smoking-cessation treatment combining transdermal nicotine substitution with behavioral therapy. Pharmacopsychiatry 1991;24:96-102.
8. Buchkremer G, Minneker E, Block M. Smoking-cessation treatment combining transdermal nicotine substitution with behavioral therapy. Pharmacopsychiatry 1991;24:96-102.
9. Conway TL, Woodruff SI, Edwards CC, Elder JP, Hurtado SL, Hervig LK. Operation Stay Quit: evaluation of two smoking relapse prevention strategies for women after involuntary cessation during US Navy recruit training. Military Medicine 2004;169:236-42.
10. Edwards CC, Woodruff SI, Conway TL. Operation Stay Quit: Preventing smoking relapse among US Navy women. American Journal of Health Behavior 1999;23(5):352-5.
11. Covey LS, Glassman AH, Jiang H, Fried J, Masmela J, LoDuca C, et al. A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapse. Addiction 2007;102(8):1292-302.
12. Croghan IT, Hurt RD, Dakhil SR, Croghan GA, Sloan JA, Novotny PJ, et al. Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention. Mayo Clinic Proceedings 2007;82(2):186-95.
13. Curry SJ, Marlatt GA, Gordon J, Baer JS. A comparison of alternative theoretical approaches to smoking cessation and relapse. Health Psychology 1988;7(6):545-56.
14. Davis JR, Glaros AG. Relapse prevention and smoking cessation. Addictive Behaviors 1986;11:105-14.
15. Emmons KM, Emont SL, Collins RL, Weidner G. Relapse prevention versus broad spectrum treatment for smoking cessation: a comparison of efficacy. Journal of Substance Abuse 1988;1:79-89.
16. Ershoff DH, Quinn VP, Mullen PD. Relapse prevention among women who stop smoking early in pregnancy: a randomized clinical trial of a self-help intervention. American Journal of Preventive Medicine 1995;11(3):178-84.
17. Fortmann SP, Killen JD. Nicotine gum and self-help behavioral treatment for smoking relapse prevention: results from a trial using population-based recruitment. Journal of Consulting and Clinical Psychology 1995;63(3):460-8.
18. Hajek P, West R, Lee A, Foulds J, Owen L, Eiser JR, et al. Randomized controlled trial of a midwife-delivered brief smoking cessation intervention in pregnancy. Addiction 2001;96(3):485-94.
19. Hajek P, Taylor TZ, Mills P. Brief intervention during hospital admission to help patients to give up smoking after myocardial infarction and bypass surgery: randomised controlled trial. BMJ 2002;324:87-9.
20. Hall SM, Rugg D, Tunstall C, Jones RT. Preventing relapse to cigarette smoking by behavioral skill training. Journal of Consulting and Clinical Psychology 1984;52(3):372-82.
21. Hall SM, Killen JD. Psychological and pharmacological approaches to smoking relapse prevention. NIDA Research Monograph 1985;53:131-43.
22. Hall SM, Tunstall C, Rugg D, Jones R, Benowitz N. Nicotine gum and behavioral treatment in smoking cessation. Journal of Consulting and Clinical Psychology 1985;53:256-8.
23. Hall SM, Tunstall CD, Ginsberg D, Benowitz NL, Jones RT. Nicotine gum and behavioral treatment: a placebo controlled trial. Journal of Consulting and Clinical Psychology 1987;55(4):603-5.
24. Hannöver W, Thyrian JR, Roske K, Grempler J, Rumpf HJ, John U, et al. Smoking cessation and relapse prevention for postpartum women: results from a randomized controlled trial at 6, 12, 18 and 24 months. Addictive Behaviors 2009;34:1-8. [DOI: 10.1016/j.addbeh.2008.07.021]
25. Roske K, Schumann A, Hannöver W, Grempler J, Thyrian JR, Rumpf HJ, et al. Postpartum smoking cessation and relapse prevention intervention: a structural equation modeling application to behavioral and non-behavioral outcomes of a randomized controlled trial. Journal of Health Psychology 2008;13:556-68.
26. Thyrian JR, Freyer-Adam J, Hannöver W, Roske K, Mentzel F, Kufeld C, et al. Adherence to the principles of motivational interviewing, clients' characteristics and behavior outcome in a smoking cessation and relapse prevention trial in women postpartum. Addictive Behaviors 2007;32:2297-303.
27. Hasuo S, Tanaka H, Oshima A. [Efficacy of a smoking relapse prevention program by postdischarge telephone contacts: a randomized trial] [Japanese]. Nippon Koshu Eisei Zasshi 2004;51:403-12.
28. Abel GA, Hays JT, Decker PA, Croghan GA, Kuter DJ, Rigotti NA. Effects of biochemically confirmed smoking cessation on white blood cell count. Mayo Clinic Proceedings 2005;80:1022-8.
29. Cox LS, Patten CA, Niaura RS, Decker PA, Rigotti N, Sachs DPL, et al. Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression. Journal of General Internal Medicine 2004;19:828-34.
30. Durcan MJ, Deener G, White J, Johnston JA, Gonzales D, Niaura R, et al. The effect of bupropion sustained-release on cigarette craving after smoking cessation. Clinical Therapeutics 2002;24(4):540-51.
31. Durcan MJ, Johnston JA, White J, Gonzales D, Sachs DP, Rigotti N, et al. Bupropion SR for relapse prevention: a "slips-allowed" analysis. American Journal of Health Behavior 2004;28:456-63.
32. Gonzales D, Bjornson W, Durcan MJ, White JD, Johnston JA, Buist AS, et al. Effects of gender on relapse prevention in smokers treated with bupropion SR. American Journal of Preventive Medicine 2002;22(4):234-9.
33. Hays JT, Hurt RD, Rigotti NA, Niaura R, Gonzales D, Durcan MJ, et al. Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. A randomized, controlled trial. Annals of Internal Medicine 2001;135:423-33.
34. Hurt RD, Wolter TD, Rigotti N, Hays JT, Niaura R, Durcan MJ, et al. Bupropion for pharmacologic relapse prevention to smoking - Predictors of outcome. Addictive Behaviors 2002;27(4):493-507.
35. Hays JT, Hurt RD, Decker PA, Croghan IT, Offord KP, Patten CA. A randomized, controlled trial of bupropion sustained-release for preventing tobacco relapse in recovering alcoholics. Nicotine and Tobacco Research 2009;11(7):859-67.
36. Hurt RD, Krook JE, Croghan IT, Loprinzi CL, Sloan JA, Novotny PJ, et al. Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking. Journal of Clinical Oncology 2003;21:914-20.
37. Japuntich SJ, Zehner ME, Smith SS, Jorenby DE, Valdez JA, Fiore MC, et al. Smoking cessation via the internet: a randomized clinical trial of an internet intervention as adjuvant treatment in a smoking cessation intervention. Nicotine & Tobacco Research 2006;8 Suppl 1:S59-67.
38. Joseph AM, Fu SS, Lindgren B, Rothman AJ, Kodl M, Lando H, et al. Chronic disease management for tobacco dependence: a randomized, controlled trial. Archives of Internal Medicine 2011;171(21):1894-900.
39. Juliano LM, Houtsmuller EJ, Stitzer ML. A preliminary investigation of rapid smoking as a lapse-responsive treatment for tobacco dependence. Experimental & Clinical Psychopharmacology 2006;14:429-38.
40. Killen JD, Maccoby N, Taylor CB. Nicotine gum and self-regulation training in smoking relapse prevention. Behavior Therapy 1984;15:234-48.
41. Killen JD, Fortmann SP, Newman B, Varady A. Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for smoking relapse prevention. Journal of Consulting and Clinical Psychology 1990;58:85-92.
42. Killen JD, Fortmann SP, Murphy GM Jr, Hayward C, Arredondo C, Cromp D, et al. Extended treatment with bupropion SR for cigarette smoking cessation. Journal of Consulting and Clinical Psychology 2006;74(2):286-94.
43. Klesges RC, Haddock CK, Lando H, Talcott GW. Efficacy of forced smoking cessation and an adjunctive behavioral treatment on long-term smoking rates. Journal of Consulting and Clinical Psychology 1999;67:952-8.
44. Klesges RC, Debon M, Vander Weg MW, Haddock CK, Lando HA, Relyea GE, et al. Efficacy of a tailored tobacco control program on long-term use in a population of U.S. military troops. Journal of Consulting & Clinical Psychology 2006;74(2):295-306.
45. Klesges RC, Sherrill-Mittleman D, Ebbert JO, Talcott GW, Debon M. Tobacco use harm reduction, elimination, and escalation in a large military cohort. American Journal of Public Health 2010;100(12):2487-92.
46. Lando HA, Pirie PL, Roski J, McGovern PG, Schmid LA. Promoting abstinence among relapsed chronic smokers: the effect of telephone support. American Journal of Public Health 1996;86:1786-90.
47. Lifrak P, Gariti P, Alterman A, Volpicelli J, O'Brien C. Combining individual relapse prevention counseling with a transdermal nicotine patch for smoking cessation. Journal of Addictive Diseases 1994;13(4):251.
48. Lifrak P, Gariti P, Alterman AI, McKay J, Volpicelli J, Sparkman T, et al. Results of two levels of adjunctive treatment used with the nicotine patch. American Journal of Addiction 1997;6:93-8.
49. Lowe JB, Windsor R, Balanda KP, Woodby L. Smoking relapse prevention methods for pregnant women: a formative evaluation. American Journal of Health Promotion 1997;11:244-6.
50. Mayer C, Vandecasteele H, Bodo M, Primo C, Slachmuylder JL, Kaufman L, et al. Smoking relapse prevention programs and factors that predict abstinence: a controlled study comparing the efficacy of workplace group counselling and proactive phone counselling. Journal of Smoking Cessation 2010;5(1):83-94.
51. McBride CM, Curry SJ, Lando HA, Pirie PL, Grothaus LC, Nelson JC. Prevention of relapse in women who quit smoking during pregnancy. American Journal of Public Health 1999;89:706-11.
52. McBride CM, Baucom DH, Peterson BL, Pollak KI, Palmer C, Westman E, et al. Prenatal and postpartum smoking abstinence - A partner-assisted approach. American Journal of Preventive Medicine 2004;27(3):232-8.
53. Mermelstein R, Hedeker D, Wong SC. Extended telephone counseling for smoking cessation: does content matter?. Journal of Consulting and Clinical Psychology 2003;71:565-74.
54. Morasco BJ, Dornelas EA, Fischer EH, Oncken C, Lando HA. Spontaneous smoking cessation during pregnancy among ethnic minority women: a preliminary investigation. Addictive Behaviors 2006;31(2):203-10.
55. Niaura R, Abrams DB, Shadel WG, Rohsenow DJ, Monti PM, Sirota AD. Cue exposure treatment for smoking relapse prevention: a controlled clinical trial. Addiction 1999;94(5):685-96.
56. Pbert L, Ockene JK, Zapka J, Ma YS, Goins KV, Oncken C, et al. A community health center smoking-cessation intervention for pregnant and postpartum women. American Journal of Preventive Medicine 2004;26(5):377-85.
57. Powell DR, McCann BS. The effects of a multiple treatment program and maintenance procedures on smoking cessation. Preventive Medicine 1981;10:94-104.
58. Johnson JL, Ratner PA, Bottorff JL, Hall W, Dahinten S. Preventing smoking relapse in postpartum women. Nursing Research 2000;49:44-52.
59. Ratner PA, Johnson JL, Bottorff JL. Smoking relapse and early weaning among postpartum women: is there an association?. Birth 1999;26(2):76-82.
60. Ratner PA, Johnson JL, Bottorff JL, Dahinten S, Hall W. Twelve-month follow-up of a smoking relapse prevention intervention for postpartum women. Addictive Behaviors 2000;25:81-92.
61. Razavi D, Vandecasteele H, Primo C, Bodo M, Debrier F, Verbist H, et al. Maintaining abstinence from cigarette smoking: effectiveness of group counselling and factors predicting outcome. European Journal of Cancer 1999;35:1238-47.
62. Heppner WL, Ji L, Reitzel LR, Reitzel L, Castro Y, Correa-Fernandez V, et al. The role of prepartum motivation in the maintenance of postpartum smoking abstinence. Health Psychology 2011;30(6):736-45.
63. Reitzel LR, Vidrine JI, Businelle MS, Kendzor DE, Costello TJ, Li Y, et al. Preventing postpartum smoking relapse among diverse low-income women: a randomized clinical trial. Nicotine & Tobacco Research 2010;12(4):326-35.
64. Ruger JP, Weinstein MC, Hammond SK, Kearney MH, Emmons KM. Cost-effectiveness of motivational interviewing for smoking cessation and relapse prevention among low-income pregnant women: a randomized controlled trial. Value in Health 2008;11:191-8.
65. Schmitz JM, Spiga R, Rhoades HM, Fuentes F. Smoking cessation in women with cardiac risk: a comparative study of two theoretically based therapies. Nicotine & Tobacco Research 1999;1(1):87-94.
66. Schroter M, Collins SE, Frittrang T, Buchkremer G, Batra A. Randomized controlled trial of relapse prevention and a standard behavioral intervention with adult smokers. Addictive Behaviors 2006;31(7):1259-64.
67. Secker-Walker RH, Solomon LJ, Flynn BS, Skelly JM, LePage SS, Goodwin GD, et al. Smoking relapse prevention counseling during prenatal and early postnatal care. American Journal of Preventive Medicine 1995;11:86-93.
68. Secker-Walker RH, Solomon LJ, Flynn BS, Skelly JM, Mead PB. Smoking relapse prevention during pregnancy. A trial of coordinated advice from physicians and individual counseling. American Journal of Preventive Medicine 1998;15:25-31.
69. Segan CJ, Borland R. Does extended telephone callback counselling prevent smoking relapse?. Health Education Research 2011;26(2):336-47.
70. Severson HH, Andrews JA, Lichtenstein E, Wall M, Akers L. Reducing maternal smoking and relapse: long-term evaluation of a pediatric intervention. Preventive Medicine 1997;26:120-30.
71. Wall MA, Severson HH, Andrews JA, Lichtenstein E, Zoref L. Pediatric office-based smoking intervention - Impact on maternal smoking and relapse. Pediatrics 1995;96:622-8.
72. Sheffer CE, Stitzer M, Brandon T, Bursac Z. Effectiveness of adding relapse prevention materials to telephone counselling. Journal of Substance Abuse Treatment 2010;39:71-7.
73. Shoptaw S, Rotheram-Fuller E, Yang X, Frosch D, Nahom D, Jarvik ME, et al. Smoking cessation in methadone maintenance. Addiction 2002;97:1317-28.
74. Smith SS, Jorenby DE, Fiore MC, Anderson JE, Mielke MM, Beach KE, et al. Strike while the iron is hot: can stepped-care treatments resurrect relapsing smokers?. Journal of Consulting and Clinical Psychology 2001;69:429-39.
75. Stevens VJ, Hollis JF. Preventing smoking relapse, using an individually tailored skills-training technique. Journal of Consulting and Clinical Psychology 1989;57:420-4.
76. Niaura R. Long-term maintenance of abstinence from smoking with rimonabant: results from the STRATUS Worldwide trial. 1-Year efficacy/safety results. American Thoracic Society Conference. 2005. [clinical trials.gov ID NCT00459173]
77. Niaura R. Long-term maintenance of abstinence from smoking with rimonabant: results from the STRATUS Worldwide trial. 6-Month efficacy/safety results [POS1-054]. American Thoracic Society Conference. 2004.
78. Sanofi Aventis. Information meeting, 2005. http://en.sanofi-aventis.com/Images/en_050301_up_2004_Full_Year_Results_Analysts_Investors_meeting_in_Paris_presentation_tcm24-3612.pdf (accessed 23 November 2006).
79. Bolin K, Mörk A-C, Wilson K. Smoking-cessation therapy using varenicline: the cost-utility of an additional 12-week course of varenicline for the maintenance of smoking abstinence. Journal of Evaluation in Clinical Practice 2009;15:478-85.
80. Hajek P, Tønneson P, Arteaga C, Russ C, Tonstad S. Varenicline in prevention of relapse to smoking: effect of quit pattern on response to extended treatment. Addiction 2009;104:1597-602.
81. Knight C, Howard P, Baker CL, Marton JP. The cost-effectiveness of an extended course (12 + 12 weeks) of varenicline compared with other available smoking cessation strategies in the United States: an extension and update to the BENESCO model. Value in Health 2010;13(2):209-14.
82. Knight CJ, Howard PA, Baker CL. An evaluation of the cost-effectiveness of an extended course of varenicline in preventing smokers who have quit from relapsing [PSM3]. Value in Health 2007; Vol. 10, issue 6:A472.
83. Lee JH, Jones PG, Bybee K, O'Keefe JH. A longer course of varenicline therapy improves smoking cessation rates. Preventive Cardiology 2008;11(4):210-4.
84. O'Brien CP. Varenicline as maintenance therapy. Current Psychiatry Reports 2007;9(5):348-8.
85. Tonstad S, Tonnesen P, Hajek P, Williams KE, Billing CB, Reeves KR. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. JAMA 2006;296:64-71.
86. Van't Hof SM, Wall MA, Dowler DW, Stark MJ. Randomised controlled trial of a postpartum relapse prevention intervention. Tobacco Control 2000;9 Suppl 3:III64-6.
87. van Osch L, Lechner L, Reubsaet A, Wigger S, de Vries H. Relapse prevention in a national smoking cessation contest: effects of coping planning. British Journal of Health Psychology 13;2008:525-35.
88. Wetter D, McClure J. A randomized clinical trial of a palmtop computer-delivered treatment for smoking relapse prevention among women. Psychology of Addictive Behaviours 2011;25(2):365-71.
89. Adams KK, Merritt TA. Prevention of postpartum smoking relapse in mothers to prevent infant exposure to second-hand smoke. Journal of Investigative Medicine 2011;59:102.
90. Allen S, Bade T, Hatsukami D. Smoking relapse in women: effect of menstrual phase. SYM 10B Society for Research on Nicotine and Tobacco 13th Annual Meeting; 2007 February 21-24; Austin, TX.
91. Alterman AI, Gariti P, Mulvaney F. Short- and long-term smoking cessation for three levels of intensity of behavioral treatment. Psychology of Addictive Behaviors 2001;15(3):261-4.
92. Bottausci AJ. An experimental study of cue exposure as a relapse prevention technique in smoking cessation maintenance. Masters Abstracts International 1995;32(3):1063.
93. Brown RA, Kahler CW, Niaura R, Abrams DB, Sales SD, Ramsey SE, et al. Cognitive-behavioral treatment for depression in smoking cessation. Journal of Consulting and Clinical Psychology 2001;69:471-80.
94. Carmody TP, Loew DE, Hall RG, Breckenridge JS. Nicotine polacrilex: clinic-based strategies with chronically ill smokers. Special Issue. Pharmacological adjuncts and nutritional supplements in the treatment of drug dependence. Journal of Psychoactive Drugs 1988;20(3):269-74.
95. Cinciripini PM, McClure JB, Wetter DW, Perry J, Blalock JA, Cinciripini LG, et al. An evaluation of videotaped vignettes for smoking cessation and relapse prevention during pregnancy: the very important pregnant smokers (VIPS) program. Tobacco Control 2000;9 Suppl:III, 61-3.
96. Copeland AL, Martin PD, Geiselman PJ, Rash CJ, Kendzor DE. Smoking cessation for weight-concerned women: group vs. individually tailored, dietary, and weight-control follow-up sessions. Addictive Behaviors 2006;31(1):115-27.
97. Davis MJ, Baker LJV. Smoking cessation: the use of a choice of strategies to aid cessation and maintenance. Irish Journal of Psychology 1995;16(2):150-61.
98. DiSantis KI, Collins BN, McCoy AC. Associations among breastfeeding, smoking relapse, and prenatal factors in a brief postpartum smoking intervention. Acta Obstetricia Et Gynecologica Scandinavica 2010;89(4):582-6.
99. Dooley RT, Halford WK. A comparison of relapse prevention with nicotine gum or nicotine fading in modification of smoking. Australian Psychology 1992;27(3):186-91.
100. Dubren R. Self-reinforcement by recorded telephone messages to maintain non-smoking behavior. Journal of Consulting and Clinical Psychology 1977;45:358-60.
101. Dunphy PM. Using an empowerment and education intervention to prevent smoking relapse in the early postpartum period [dissertation]. Philadelphia: University of Pennsylvania, 2000.
102. Elfeddali I, Bolman C, Candel MJ, Wiers RW, de Vries H. Preventing smoking relapse via Web-based computer-tailored feedback: a randomized controlled trial. Journal of Medical Internet Research 2012;14(4):e109.
103. Evins AE, Pachas G, Mischoulon D, Urbanoski K, Carlini S, Sousa J, et al. A double-blind, placebo-controlled trial of the NMDA glycine site antagonist, GW468816, for prevention of relapse to smoking in females. Journal of Clinical Psychopharmacology 2011;31(5):597-602.
104. Feeney GF, McPherson A, Connor JP, McAlister A, Young MR, Garrahy P. Randomized controlled trial of two cigarette quit programmes in coronary care patients after acute myocardial infarction. Internal Medicine Journal 2001;31(8):470-5.
105. French GM, Groner JA, Wewers ME, Ahijevych K. Staying smoke free: an intervention to prevent postpartum relapse. Nicotine & Tobacco Research 2007;9(6):663-70.
106. Froelicher ES, Christopherson DJ. Women's Initiative for Nonsmoking (WINS) I: design and methods. Heart & Lung 2000;29(6):429-37.
107. Garvey AJ, Kalman D, Hoskinson RA Jr, Kinnunen T, Wadler BM, Thomson CC, et al. Front-loaded versus weekly counseling for treatment of tobacco addiction. Nicotine & Tobacco Research 2012;14(5):578-85.
108. George TP, Ziedonis DM, Feingold A, Pepper WT, Satterburg CA, Winkel J, et al. Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. American Journal of Psychiatry 2000;157(11):1835-42.
109. Goldstein MG, Niaura R, Follick MJ, Abrams DB. Effects of behavioral skills training and schedule of nicotine gum administration on smoking cessation. American Journal of Psychiatry 1989;146:56-60.
110. Gruder CL, Mermelstein RJ, Kirkendol S, Hedeker D, Wong SC, Schreckengost J, et al. Effects of social support and relapse prevention training as adjuncts to a televised smoking-cessation intervention. Journal of Consulting and Clinical Psychology 1993;61(1):113-20.
111. Warnecke RB, Flay BR, Kviz FJ, Gruder CL, Langenberg P, Crittenden KS, et al. Characteristics of participants in a televised smoking cessation intervention. Preventive Medicine 1991;20:389-403.
112. Hall SM, Munoz RF, Reus VI. Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers. Journal of Consulting and Clinical Psychology 1994;62(1):141-6.
113. Hall SM, Munoz RF, Reus VI, Sees KL, Duncan C, Humfleet GL, et al. Mood management and nicotine gum in smoking treatment - A therapeutic contact and placebo-controlled study. Journal of Consulting and Clinical Psychology 1996;64:1003-9.
114. Hall SM, Reus VI, Munoz RF, Sees KL, Humfleet G, Hartz DT, et al. Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Archives of General Psychiatry 1998;55:683-90.
115. Hall SM, Reus VI, Munoz RF, Sees KL, Humfleet GL, Frederick S. Nortriptyline and cognitive-behavioral treatment of cigarette smoking. Proceedings of the CPDD Annual Meeting; San Juan, Puerto Rico; 1996:52.
116. Hall SM, Humfleet GL, Muñoz RF, Reus VI, Prochaska JJ, Robbins JA. Using extended cognitive behavioral treatment and medication to treat dependent smokers. American Journal of Public Health 2011;101(12):2349-56.
117. Prochaska JJ, Hall SM, Humfleet G, Munoz RF, Reus V, Gorecki J, et al. Physical activity as a strategy for maintaining tobacco abstinence: a randomized trial. Preventive Medicine 2008;47(2):215-20.
118. Klesges R, Glasgow RE, Klesges L, Morray K, Quale R. Competition and relapse prevention training in worksite smoking modification. Health Education Research 1987;2:5-14.
119. Lando HA, Rolnick S, Klevan D, Roski J, Cherney L, Lauger G. Telephone support as an adjunct to transdermal nicotine in smoking cessation. American Journal of Public Health 1997;87:1670-4.
120. Rolnick SJ, Klevan D, Cherney L, Lando HA. Nicotine replacement therapy in a group model HMO. HMO Practice 1997;11:34-7.
121. Macleod ZR, Charles MA, Arnaldi VC, Adams IM. Telephone counselling as an adjunct to nicotine patches in smoking cessation: a randomised controlled trial. Medical Journal of Australia 2003;179:349-52.
122. Miller NH, Smith PM, DeBusk RF, Sobel DS, Taylor CB. Smoking cessation in hospitalized patients - Results of a randomized trial. Archives of Internal Medicine 1997;157:409-15.
123. Taylor CB, Miller NH, Herman S, Smith PM, Sobel D, Fisher L, et al. A nurse-managed smoking cessation program for hospitalized smokers. American Journal of Public Health 1996;86:1557-60.
124. Phillips RM, Merritt TA, Goldstein MR, Deming DD, Slater LE, Angeles DM. Supporting mother-infant bonding increases the duration of breastfeeding in mothers with newborns in the neonatal intensive care unit. Breastfeeding Medicine 2011;6:S4.
125. Phillips RM, Merritt TA, Goldstein MR, Deming DD, Slater LE, Angeles DM. Prevention of postpartum smoking relapse in mothers of infants in the neonatal intensive care unit. Journal of Perinatology 2012;32(5):374-80.
126. Reid RD, Pipe A, Dafoe WA. Is telephone counselling a useful addition to physician advice and nicotine replacement therapy in helping patients to stop smoking? A randomized controlled trial. Canadian Medical Association Journal 1999;160:1577-81.
127. Solomon LJ, Scharoun GM, Flynn BS, Secker-Walker RH, Sepinwall D. Free nicotine patches plus proactive telephone peer support to help low-income women stop smoking. Preventive Medicine 2000;31:68-74.
128. Storro O, Oien T, Johnsen R. Preventing relapse of smoking among postnatal women and their partners in primary care: a controlled birth cohort intervention study. Allergy 2008;63(Suppl 88):483.
129. Tonstad S, Heggen E, Giljam H, Lagerbäck PA, Tønnesen P, Wikingsson LD, et al. Niccine®, a nicotine vaccine for relapse prevention: a phase II, randomized, placebo-controlled, multicenter clinical trial. Nicotine & Tobacco Research 2013. [Epub ahead of print].
130. Yoon JH, Higgins ST, Bradstreet MP, Badger GJ, Thomas CS. Changes in the relative reinforcing effects of cigarette smoking as a function of initial abstinence. Psychopharmacology 2009;205(2):305-18.
131. Zelman DC, Brandon TH, Jorenby DE, Baker TB. Measures of affect and nicotine dependence predict differential response to smoking cessation treatments. Journal of Consulting and Clinical Psychology 1992;60:943-52.
132. Getting Physical on Cigarettes - Smoking Cessation & Relapse Prevention. Clinicaltrials.gov 2011 http://clinicaltrials.gov/ct2/show/NCT01305447.
133. Jung ME, Fitzgeorge L, Prapavessis H, Faulkner G, Maddison R. The getting physical on cigarettes trial: rationale and methods. Mental Health and Physical Activity 2010;3(1):35-44.
134. Massachusetts General Hospital. A study of varenicline for prevention of relapse to smoking in patients with schizophrenia, 2008. http://clinicaltrials.gov/ct2/show/NCT00621777 (accessed 1 June 2012).
135. Williams GC, Patrick H, Niemiec CP, Ryan RM, Deci EL, Lavigne HM. The smoker's health project: a self-determination theory intervention to facilitate maintenance of tobacco abstinence. Contemporary Clinical Trials 2011;32(4):535-43.
136. Agboola S, McNeill A, Coleman T, Leonardi Bee J. A systematic review of the effectiveness of smoking relapse prevention interventions for abstinent smokers. Addiction 2010;105(8):1362-80.
137. Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database of Systematic Reviews 2013, Issue 5. [DOI: 10.1002/14651858.CD009329.pub2]
138. Coleman T, Agboola S, Leonardi-Bee J, Taylor M, McEwen A, McNeill A. Relapse prevention in UK Stop Smoking Services: current practice, systematic reviews of effectiveness and cost-effectiveness analysis. Health Technology Assessment 2010;14(49):1-152.
139. Deeks JJ. Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes. Statistics in Medicine 2002;21:1575-600.
140. Hajek P. Appraising the efficacy of psychological treatments for smokers. Journal of Smoking-Related Disorders 1994;5:101-7.
141. Hajek P, Stead LF. Aversive smoking for smoking cessation. Cochrane Database of Systematic Reviews 2001, Issue 3. [DOI: 10.1002/14651858.CD000546.pub2]
142. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;7414:557-60.
143. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD000031.pub2]
144. Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD001292.pub2]
145. Marlatt A, Gordon J. Relapse Prevention. New York: Guilford Press, 1985.
146. Marlatt GA, Donovan DM, editors. Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviours. 2nd Edition. New York: Guilford Press, 2008.
147. Ossip-Klein DJ, Bigelow G, Parker SR, Curry S, Hall S, Kirkland S. Classification and assessment of smoking behavior. Health Psychology 1986;5 Suppl:3-11.
148. Rigotti NA, Munafo MR, Stead LF. Interventions for smoking cessation in hospitalised patients. Cochrane Database of Systematic Reviews 2012, Issue 5. [DOI: 10.1002/14651858.CD001837.pub3]
149. Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database of Systematic Reviews 2005, Issue 3. [DOI: 10.1002/14651858.CD001007.pub2]
150. Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews 2012, Issue 11. [DOI: 10.1002/14651858.CD000146.pub4]
151. Ussher MH, Taylor AH, Faulkner G. Exercise interventions for smoking cessation. Cochrane Database of Systematic Reviews 2012, Issue 1. [DOI: 10.1002/14651858.CD002295.pub4]
152. Hajek P, Stead LF, West R, Jarvis M, Lancaster T. Relapse prevention interventions for smoking cessation. Cochrane Database of Systematic Reviews 2005, Issue 1. [DOI: 10.1002/14651858.CD003999.pub2]
153. Hajek P, Stead LF, West R, Jarvis M, Lancaster T. Relapse prevention interventions for smoking cessation. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD003999.pub3]